Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis

Although there have been recent advances in irradiation techniques and the use of concurrent chemo-radiotherapy, local recurrence still remains a major cause of therapeutic failure in patients with nasopharyngeal carcinoma (NPC), with a rate of approximately 8 –10% [1,2]. It is still a challenge in clinical practice to implement effective treatment for patients with locally recurrent NPC (r-NPC) who had received a previous full-dose of radiation therapy (RT), especially in patients with advanced T stage and/ or a bulky tumor volume [3].

Source: Oral Oncology - May 2, 2018 Category: Cancer & Oncology Authors: Qiuyuan Yue, Mingwei Zhang, Yunbin Chen, Dechun Zheng, Ying Chen, Meimei Feng Tags: Review Source Type: research